Permanens Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Permanens Capital’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-359,311	Closed	-$3.38M	–	133
2020 Q3	$3.38M	Sell	359,311 -150	-0%	-$1.43K	1.17%	9
2020 Q2	$2.75M	Sell	359,461 -125,000	-26%	-$956K	1.04%	6
2020 Q1	$2.99M	Buy	484,461 +31,500	+7%	+$278K	0.95%	7
2019 Q4	$5.51M	Buy	452,961 +45,150	+11%	+$493K	1.38%	9
2019 Q3	$4.71M	Buy	407,811 +141,311	+53%	+$1.49M	1.32%	9
2019 Q2	$2.66M	Buy	266,500 +203,000	+320%	+$2.19M	0.76%	11
2019 Q1	$818K	Buy	+63,500	New	+$946K	0.24%	22

Permanens Capital's AMAG Position: Q4 2020 in Review

Permanens Capital sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 359,311 shares — an estimated $3.38M sold.

Permanens Capital first reported a position in AMAG in Q1 2019 and held it in 7 quarters. The position peaked at $5.51M in Q4 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Permanens Capital reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Permanens Capital sold 359,311 AMAG Pharmaceuticals shares in Q4 2020, an estimated $3.38M.
Permanens Capital first reported a position in AMAG Pharmaceuticals in Q1 2019 and held it in 7 quarters.
Permanens Capital's AMAG Pharmaceuticals position peaked at $5.51M in Q4 2019.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Permanens Capital's 13F filing for Q4 2020, filed 12 Feb 2021.